{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:24:42Z","timestamp":1785731082096,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["D18007"],"award-info":[{"award-number":["D18007"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32102679"],"award-info":[{"award-number":["32102679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX24_2322"],"award-info":[{"award-number":["SJCX24_2322"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2604200"],"award-info":[{"award-number":["2022YFC2604200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128767","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:49:23Z","timestamp":1780004963000},"page":"128767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines"],"prefix":"10.1016","volume":"87","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128767_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127602","article-title":"Mucosal COVID-19 vaccines in clinical development","volume":"63","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128767_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127356","article-title":"A review of currently licensed mucosal COVID-19 vaccines","volume":"61","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128767_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines6030037","article-title":"Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system","volume":"6","author":"Mohsen","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128767_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.22218","article-title":"Plant-derived virus-like particles as vaccines","volume":"9","author":"Chen","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128767_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrc.2018.13","article-title":"Opportunities and challenges for human papillomavirus vaccination in cancer","volume":"18","author":"Roden","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.vaccine.2026.128767_bb0030","doi-asserted-by":"crossref","first-page":"20160268","DOI":"10.1098\/rstb.2016.0268","article-title":"Tumour virus vaccines: Hepatitis B virus and human papillomavirus","volume":"372","author":"Stanley","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2026.128767_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/v14102087","article-title":"Baculovirus-free SARS-CoV-2 virus-like particle production in insect cells for rapid neutralization assessment","volume":"14","author":"Jaron","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128767_bb0040","author":"WHO COVID-19 Dashboard"},{"key":"10.1016\/j.vaccine.2026.128767_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110285","article-title":"Strengths and limitations of SARS-CoV-2 virus-like particle systems","volume":"601","author":"Sultana","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128767_bb0050","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128767_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin-a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp Mol Med"},{"issue":"32","key":"10.1016\/j.vaccine.2026.128767_bb0060","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128767_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw015","article-title":"Phase 1 safety and immunogenicity study of a quadrivalent seasonal flu vaccine comprising recombinant hemagglutinin-flagellin fusion proteins","volume":"3","author":"Tussey","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128767_bb0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41541-021-00379-4","article-title":"Deimmunization of flagellin for repeated administration as a vaccine adjuvant","volume":"6","author":"Khim","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128767_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2018.10.027","article-title":"The optimized fusion protein HA1-2-FliC\u0394D2D3 promotes mixed Th1\/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice","volume":"6","author":"Song","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2026.128767_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00326","article-title":"Mucosal and systemic immune responses to influenza H7N9 antigen HA1-2 co-delivered intranasally with flagellin or polyethyleneimine in mice and chickens","volume":"8","author":"Song","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128767_bb0085","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular architecture of the SARS-CoV-2 virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128767_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fbioe.2020.00862","article-title":"Construction of SARS-CoV-2 virus-like particles by mammalian expression system","volume":"8","author":"Xu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.vaccine.2026.128767_bb0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128767_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12916-022-02312-5","article-title":"Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 omicron variant","volume":"20","author":"Schubert","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128767_bb0105","doi-asserted-by":"crossref","unstructured":"Wu L, Zhou L, Mo M, Liu T, Wu C, Gong C, et al. SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2. Signal Transduct Target Ther 2022; 7: 8. doi:https:\/\/doi.org\/10.1038\/s41392-021-00863-2.","DOI":"10.1038\/s41392-021-00863-2"},{"key":"10.1016\/j.vaccine.2026.128767_bb0110","doi-asserted-by":"crossref","unstructured":"Struble LR, Smith AL, Lutz WE, Grubbs G, Sagar S, Bayles KW, et al. Insect cell expression and purification of recombinant SARS-CoV-2 spike proteins that demonstrate ACE2 binding. Protein Sci 2022; 31: e4300. doi:https:\/\/doi.org\/10.1002\/pro.4300.","DOI":"10.1002\/pro.4300"},{"key":"10.1016\/j.vaccine.2026.128767_bb0115","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.167.12.7009","article-title":"Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein","volume":"167","author":"Eaves-Pyles","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128767_bb0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128767_bb0125","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2026.128767_bb0130","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3389\/fimmu.2018.03054","article-title":"Studies on the use of flagellin as an immunostimulant and vaccine adjuvant in fish aquaculture","volume":"9","author":"Wangkahart","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128767_bb0135","doi-asserted-by":"crossref","DOI":"10.1128\/aem.00674-25","article-title":"Harnessing flagellin of Ligilactobacillus agilis as a surface display scaffold for an HIV-1 epitope","volume":"91","author":"Suzuki","year":"2025","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2026.128767_bb0140","article-title":"A conserved TLR5 binding and activation hot spot on flagellin","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128767_bb0145","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/immunohorizons.1800061","article-title":"Flic\u2019s hypervariable D3 domain is required for robust anti-flagellin primary antibody responses","volume":"3","author":"L\u00f3pez-Yglesias","year":"2019","journal-title":"Immunohorizons"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128767_bb0150","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s42003-021-01978-6","article-title":"A deimmunized and pharmacologically optimized toll-like receptor 5 agonist for therapeutic applications","volume":"4","author":"Mett","year":"2021","journal-title":"Commun Biol"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2026.128767_bb0155","article-title":"Truncated flagellin lacking the hypervariable region: a structural basis for improved immune responses and adjuvanticity","volume":"308","author":"Pang","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128767_bb0160","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/vaccines11111675","article-title":"Self-assembling nanovaccine fused with flagellin enhances protective effect against foot-and-mouth disease virus","volume":"11","author":"Pei","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128767_bb0165","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128767_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbiotec.2014.01.037","article-title":"In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections","volume":"75","author":"Savar","year":"2014","journal-title":"J Biotechnol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128767_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cellimm.2014.09.003","article-title":"Bursin-like peptide (BLP) enhances H9N2 influenza vaccine induced humoral and cell mediated immune responses","volume":"292","author":"Wang","year":"2014","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128767_bb0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imm.70001","article-title":"Flagellins as vaccine adjuvants and cancer immunotherapy: recent advances and future prospects","volume":"176","author":"Talukder","year":"2025","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128767_bb0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","article-title":"Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection","volume":"30","author":"Hong","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128767_bb0190","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.rvsc.2013.07.021","article-title":"Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen","volume":"95","author":"Hajam","year":"2013","journal-title":"Res Vet Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128767_bb0195","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.vaccine.2010.11.002","article-title":"Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of toxoplasma gondii in murine models of experimental toxoplasmosis","volume":"29","author":"Dziadek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128767_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/376505","article-title":"Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles","volume":"188","author":"Pinto","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128767_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2017.05.002","article-title":"Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: a preliminary study","volume":"187","author":"Rostami","year":"2017","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128767_bb0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/abbs\/gmw118","article-title":"Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice","volume":"49","author":"Cai","year":"2017","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128767_bb0215","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128767_bb0220","doi-asserted-by":"crossref","first-page":"11813","DOI":"10.1128\/JVI.01076-08","article-title":"Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:14:58Z","timestamp":1783113298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S0264410X26005761"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128767","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128767"}}